UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Notice of Effectiveness
Effectiveness Date:
June 1, 2022
Accession Number:
0001104659-22-066303
Submission Type:
POS AM
CIK:
0001651431
Company Name:
Checkmate Pharmaceuticals, Inc.
File Number:
333-259353